In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.
about
Japanese Surveillance Systems and Treatment for Influenza.How to approach and treat viral infections in ICU patientsPrevalence of Influenza A(H1N1)pdm09 Virus Resistant to Oseltamivir in Shiraz, Iran, During 2012 - 2013Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen.Addressing viral resistance through vaccinesCombinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in MiceComparison of three dimensional synergistic analyses of percentage versus logarithmic data in antiviral studies.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Antiviral therapy for respiratory viral infections in immunocompromised patients.Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors.Neuraminidase Gene Variations in Influenza A(H1N1)pdm09 Virus among Patients Admitted to Refferal Pulmonary Hospital, Tehran, Iran in 2009–2013.Investigating Different Mechanisms of Action in Combination Therapy for Influenza
P2860
Q30239895-18B4DACF-1F9A-4438-82BA-2054DEA9743DQ34894660-3118B6CF-5E62-4D0E-9AC1-506CDD1E068DQ36144389-A7C80F41-15EC-4618-A038-096765800BBBQ36243643-CE2B8F6E-A68A-4C53-971E-C99E5D0358CDQ36304783-E06FD74A-796B-4B4B-A02B-25DCF7E217B5Q36934209-3C0BACA4-938B-4256-8783-E5DACED3DA3DQ38694084-1F414B32-2252-43F7-8021-CF5E54169B6EQ38866173-3B433824-67A7-4002-9718-260DE7A38B19Q39076394-D5E44A65-D1C4-44D2-8A8F-859F5B5A5086Q40072156-129531C3-45AC-473F-B84B-5844F840892AQ47135641-3D67DE9C-C66B-4533-AB6E-870481BB0E76Q58573517-76C27C44-3E8F-4685-812C-EE3903013381
P2860
In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
In vitro activity of favipirav ...... emic influenza A (H1N1) virus.
@ast
In vitro activity of favipirav ...... emic influenza A (H1N1) virus.
@en
type
label
In vitro activity of favipirav ...... emic influenza A (H1N1) virus.
@ast
In vitro activity of favipirav ...... emic influenza A (H1N1) virus.
@en
prefLabel
In vitro activity of favipirav ...... emic influenza A (H1N1) virus.
@ast
In vitro activity of favipirav ...... emic influenza A (H1N1) virus.
@en
P2093
P2860
P1433
P1476
In vitro activity of favipirav ...... emic influenza A (H1N1) virus.
@en
P2093
Almut H Vollmer
Brett L Hurst
Dale L Barnard
E Bart Tarbet
Yousuke Furuta
P2860
P2888
P304
P356
10.1007/S00705-013-1922-1
P577
2013-12-06T00:00:00Z
P5875
P6179
1016294489